Thrivent Financial for Lutherans’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$53.3M Sell
185,477
-20,154
-10% -$5.79M 0.12% 216
2025
Q1
$63.4M Buy
205,631
+1,332
+0.7% +$411K 0.14% 197
2024
Q4
$72.1M Buy
204,299
+189,967
+1,325% +$67M 0.14% 197
2024
Q3
$5.14M Buy
14,332
+3,615
+34% +$1.3M 0.01% 910
2024
Q2
$3.41M Sell
10,717
-1,060
-9% -$338K 0.01% 1056
2024
Q1
$2.71M Buy
11,777
+52
+0.4% +$11.9K 0.01% 1198
2023
Q4
$2.58M Sell
11,725
-27
-0.2% -$5.94K 0.01% 1215
2023
Q3
$2.65M Sell
11,752
-340
-3% -$76.8K 0.01% 1111
2023
Q2
$2.67M Buy
12,092
+64
+0.5% +$14.1K 0.01% 1162
2023
Q1
$2.69M Sell
12,028
-112
-0.9% -$25.1K 0.01% 1100
2022
Q4
$3.38M Buy
12,140
+93
+0.8% +$25.9K 0.01% 952
2022
Q3
$2.52M Buy
12,047
+162
+1% +$33.9K 0.01% 1091
2022
Q2
$2.8M Buy
11,885
+116
+1% +$27.3K 0.01% 1047
2022
Q1
$2.11M Sell
11,769
-106
-0.9% -$19K ﹤0.01% 1292
2021
Q4
$2.57M Buy
11,875
+141
+1% +$30.5K ﹤0.01% 1228
2021
Q3
$2.17M Sell
11,734
-158
-1% -$29.2K ﹤0.01% 1296
2021
Q2
$2.13M Sell
11,892
-13,156
-53% -$2.36M ﹤0.01% 1388
2021
Q1
$4.19M Sell
25,048
-13,013
-34% -$2.18M 0.01% 989
2020
Q4
$5.78M Buy
38,061
+8,618
+29% +$1.31M 0.01% 808
2020
Q3
$2.97M Sell
29,443
-980
-3% -$99K 0.01% 972
2020
Q2
$3.68M Sell
30,423
-25,178
-45% -$3.05M 0.01% 806
2020
Q1
$5.27M Buy
55,601
+5,341
+11% +$507K 0.02% 641
2019
Q4
$4.43M Buy
50,260
+38,875
+341% +$3.42M 0.01% 766
2019
Q3
$908K Sell
11,385
-173
-1% -$13.8K ﹤0.01% 1469
2019
Q2
$902K Buy
11,558
+256
+2% +$20K ﹤0.01% 1477
2019
Q1
$1.33M Buy
11,302
+242
+2% +$28.4K ﹤0.01% 1183
2018
Q4
$1.2M Buy
11,060
+630
+6% +$68.6K ﹤0.01% 1053
2018
Q3
$1.33M Buy
10,430
+509
+5% +$65.1K ﹤0.01% 1108
2018
Q2
$1.12M Buy
9,921
+69
+0.7% +$7.81K ﹤0.01% 1192
2018
Q1
$1.11M Buy
9,852
+521
+6% +$58.5K ﹤0.01% 1183
2017
Q4
$1.38M Sell
9,331
-9
-0.1% -$1.33K ﹤0.01% 1085
2017
Q3
$1.1M Buy
9,340
+220
+2% +$25.8K ﹤0.01% 1123
2017
Q2
$1.18M Buy
9,120
+690
+8% +$89.5K ﹤0.01% 1039
2017
Q1
$1.14M Buy
8,430
+1,190
+16% +$161K ﹤0.01% 1095
2016
Q4
$1.04M Buy
7,240
+420
+6% +$60.2K ﹤0.01% 1129
2016
Q3
$805K Buy
6,820
+550
+9% +$64.9K ﹤0.01% 1226
2016
Q2
$664K Buy
6,270
+560
+10% +$59.3K ﹤0.01% 1284
2016
Q1
$636K Buy
5,710
+450
+9% +$50.1K ﹤0.01% 1272
2015
Q4
$824K Buy
5,260
+110
+2% +$17.2K ﹤0.01% 1134
2015
Q3
$676K Buy
5,150
+450
+10% +$59.1K ﹤0.01% 1087
2015
Q2
$818K Buy
4,700
+1,000
+27% +$174K ﹤0.01% 895
2015
Q1
$638K Hold
3,700
﹤0.01% 998
2014
Q4
$479K Hold
3,700
﹤0.01% 1131
2014
Q3
$476K Buy
3,700
+250
+7% +$32.2K ﹤0.01% 1132
2014
Q2
$305K Sell
3,450
-150
-4% -$13.3K ﹤0.01% 1393
2014
Q1
$339K Sell
3,600
-86,400
-96% -$8.14M ﹤0.01% 1174
2013
Q4
$10.2M Buy
90,000
+34,100
+61% +$3.86M 0.06% 305
2013
Q3
$4.41M Sell
55,900
-63,200
-53% -$4.98M 0.03% 454
2013
Q2
$7.84K Buy
+119,100
New +$7.84K 0.05% 356